Almost 40% of sells yesterday were shorts. I would have thought...

Almost 40% of sells yesterday were shorts. I would have thought share price would have steadied around 45c after all the daytraders and T+1'ers had been washed out yesterday.

Company needs to be more clear about how the FDA's requirements affects timelines for OMAPRO. In the absence of this, I suspect share price will remain under pressure.